Hundreds In Guinea Receive Experimental Ebola Vaccine; Wellcome Trust-CIDRAP Report Warns Against Complacency In Vaccine Research

Reuters: Hundreds in Guinea get Ebola vaccine in fight against flare-up
“Hundreds of possible contacts of eight people infected with Ebola in Guinea have been vaccinated with an experimental Merck vaccine to try and halt a flare-up of the deadly disease, the World Health Organization said on Friday…” (Kelland, 4/1).

Reuters: Experts warn complacency on Ebola may leave vaccine work unfinished
“…Great progress has been made in Ebola vaccine development in the last two years, according to a report by an international panel of infectious disease experts, but this ‘could grind to a halt as memories of the outbreak in West Africa begin to fade.’ ‘The job is still not done,’ said Jeremy Farrar, director of the Wellcome Trust global health charity which co-led a report on the world’s progress towards Ebola immunization…” (Kelland, 3/31).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.